EMA recommends approval of 10 new medicines
The Committee for Medicinal Products for Human Use (CHMP) of the EMA (European Medicines Agency) recommended the approval of 10 medicines at its meeting in June 2024. These include Balversa (erdafitinib) for urothelial carcinoma and Eurneffy (epinephrine), the first nasal spray for allergic emergencies.
If you need more information on regulatory issues, ELS can certainly help.
local ELS consultant or via email info@elssolutions.pt
ontact your